Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis.

Beard, Katherine; Sriwastava, Shitiz

Beard, Katherine; Sriwastava, Shitiz.

Beard K; School of Medicine, West Virginia University, United States of America; Department of Neurology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States of America.
Sriwastava S; School of Medicine, West Virginia University, United States of America; Department of Neurology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States of America; West Virginia Clinical and Translational Science Institute, United States of America. Electronic address: shitiz.sriwastava@hsc.wvu.edu.

J Neurol Sci ; 430: 120034, 2021 Nov 15.

Artículo en Inglés | MEDLINE | ID: covidwho-1525858

Asunto(s)

COVID-19; Esclerosis Múltiple; Vacunas contra la COVID-19; Humanos; Esclerosis Múltiple/tratamiento farmacológico; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: J Neurol Sci Año: 2021 Tipo del documento: Artículo País de afiliación: J.jns.2021.120034

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google